Owings Mills, Maryland Clinical Trials

A listing of Owings Mills, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 20 clinical trials
Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer

This Phase II trial will enroll approximately 180 adult male patients with an earlier histologic diagnosis of prostatic adenocarcinoma and a biochemical recurrence (BCR) within 3 years of radical prostatectomy (RP) or definitive RT and no distant metastasis or locoregional recurrence. The trial is a randomized placebo-controlled double-blind study of …

adenocarcinoma
prostate adenocarcinoma
bone scan
prostatectomy
metastasis
Chesapeake Urology Research Associates
 (7.6 away) Contact site
  • 33 views
  • 02 Sep, 2020
  • +32 other locations
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus prednisone in participants with deleterious germline or somatic Homologous Recombination Repair (HRR) gene-mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) provides superior efficacy in improving radiographic progression-free survival (rPFS).

Chesapeake Urology Associates
 (9.3 away) Contact site
  • 0 views
  • 23 Nov, 2020
  • +348 other locations
Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer

The primary goal is to prospectively estimate the median PFS of African American and Caucasian men with mCRPC taking apalutamide, abiraterone acetate, and prednisone. Secondary objectives include: PSA kinetics: to determine the duration of PSA response, time to nadir, and percent of men who achieve a PSA < 0.1; Radiographic …

apalutamide
arn-509
luteinizing hormone-releasing hormone agonist
degarelix
prostate carcinoma
Chesapeake Urology Associates
 (9.3 away) Contact site
  • 199 views
  • 01 Dec, 2019
  • +15 other locations
Muscadine Plus (MPX) In Men With Prostate Cancer

This research is being done to determine if men with rising PSA after initial therapy for localized prostate cancer who display the Alanine/Alanine SOD2 genotype of MnSOD and supplement their diet with MPX have greater decrease in PSA slope following treatment compared to men that do not supplement with MPX.

prostate tumor
definitive treatment
neutrophil count
prostate specific antigen
testosterone level
Chesapeake Urology Research Associates
 (9.3 away) Contact site
  • 22 views
  • 20 Jul, 2020
  • +13 other locations
the Safety and Tolerability of Proxalutamide (GT0918) in Subjects With Metastatic Castrate Resistant Prostate Cancer

This study is an open-label, randomized, expanded/phase II study in subjects with metastatic castrate resistant prostate cancer (mCRPC) who progressed after either abiraterone or enzalutamide. The objective of the study is to evaluate the safety and tolerability of proxalutamide and determine the RP2D for Ph III and/or other confirming studies. …

Chesapeake Urology Research Associates
 (9.3 away) Contact site
  • 7 views
  • 23 Mar, 2020
  • +9 other locations
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer

The purpose of this study is to determine the efficacy and safety of relugolix 120 milligrams (mg) orally once daily for 48 weeks on maintaining serum testosterone suppression to castrate levels (< 50 nanograms/deciliter [ng/dL]) in participants with androgen-sensitive advanced prostate cancer.

testosterone
cryotherapy
adenocarcinoma
serum testosterone
prostatectomy
Baltimore
 (7.6 away) Contact site
  • 1590 views
  • 04 Nov, 2020
  • +351 other locations
Phase 3 Study of ProstAtak Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer

The purpose of this study is to evaluate the effectiveness of ProstAtak immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a cancer vaccine effect. Killing tumor cells in an immune stimulatory environment induces the body's immune system to …

tumor cells
androgen suppression
androgens
external beam radiation therapy
cancer vaccine
Chesapeake Urology Research Associates
 (9.3 away) Contact site
  • 1420 views
  • 29 Nov, 2020
  • +76 other locations
ProSpace Balloon System Pivotal Study BP-007

The ProSpace System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the ProSpace System to reduce the radiation dose delivered to the anterior rectum. ProSpace is a balloon composed of …

adenocarcinoma
adenocarcinoma of prostate
Chesapeake Urology Research Associates
 (0.5 away) Contact site
  • 183 views
  • 30 Jul, 2020
  • +14 other locations
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutamide clinical study sponsored by Astellas or Medivation (i.e., parent study) which has completed, at a minimum, the primary …

enzalutamide
androgen suppression
antiandrogen therapy
androgens
abiraterone
Site US10029
 (7.6 away) Contact site
  • 1404 views
  • 01 Nov, 2020
  • +130 other locations
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

This is a blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with increased risk for cardiovascular (CV) disease.

serum testosterone
replacement therapy
testosterone topical
testosterone level
testosterone
Chesapeake Urology Associates /ID# 211874
 (7.6 away) Contact site
  • 16823 views
  • 29 Nov, 2020
  • +422 other locations